medac GmbH is a pharmaceutical company founded in 1970 and based in Wedel, near Hamburg, Germany. With over 2,000 employees and annual turnover of €620 million, the company develops, manufactures, and distributes pharmaceuticals and diagnostics to more than 90 countries worldwide. All manufacturing takes place in Germany and Europe, with a 98% delivery capability.
The company's product portfolio spans original pharmaceuticals, generic medicines, biosimilars, and diagnostic products. In the 2023/24 financial year, medac assembled and packaged 48 million units, including 9 million pens and 10 million syringes. Its therapeutic focus includes oncology, rheumatology, urology, and hematology.
As a privately-owned company, medac operates across the full pharmaceutical value chain - from drug development and manufacturing through packaging and logistics to marketing and distribution. The company emphasises the availability of essential treatments in areas of unmet medical need and maintains an established global supply network supported by European-based production infrastructure.
